SCHEMBL3847570

SCHEMBL3847570

CSc1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cc23)o1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
DHODH Q02127 1/20 0.32
MAP4K4 O95819 3/20 0.31
MAPK14 Q16539 2/20 0.31
CSNK1D P48730 2/20 0.31
CSNK1E P49674 2/20 0.31
MAPK13 O15264 1/20 0.31
MAPK12 P53778 1/20 0.31
KCNH2 Q12809 1/20 0.31
MAPK11 Q15759 1/20 0.31
CYP1A2 P05177 7/20 0.31
CYP3A4 P08684 7/20 0.31
ALDH1A1 P00352 6/20 0.31
MAPK1 P28482 6/20 0.31
CYP2C19 P33261 6/20 0.31
CYP2D6 P10635 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849617 0.87 PIK3CD (0.36) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3847727 0.86 PIK3CD (0.41) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3848662 0.86 PTGS2 (0.35) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3851462 0.82 PIK3CD (0.33) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3855586 0.81 LMNA (0.39) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3846869 0.81 TGFBR1 (0.35) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3848456 0.80 PTGS2 (0.46) MAPK14PTGS2
SCHEMBL3850268 0.80 PTGS2 (0.46) MAPK14PTGS2
SCHEMBL3850507 0.80 MAP4K4 (0.37) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3850673 0.79 AURKB (0.36) PIK3CDPIK3CAPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed